New Approach Cuts UTI Antibiotic Use in Women

Latest Posts

A multimodal strategy has successfully lowered the prescription of second-line antibiotics for women with urinary tract infections, according to a new study that might change the landscape of UTI therapy.

Although established guidelines advise symptomatic management and postponing antibiotic prescriptions for people with mild to moderate UTI symptoms who prefer not to take antibiotics, the standard of care in primary care frequently encourages early antibiotic use. The New England Journal of Medicine describes a study that defies this pattern, with a heavy emphasis on recommendations, regional data on medication resistance, and quarterly feedback. 

Dr. Ana Marques of the Centre Hospitalier Universitaire de Clermont-Ferrand in France led the study, which focused mostly on Germany, where yearly prescription rates for fluoroquinolones ranged from 38% to 54%. The project’s purpose was to collect resistance data at the regional level so that treatment procedures could be harmonized with best practices. 

As a result of the study’s findings, second-line antibiotics for women with uncomplicated UTIs were provided significantly less frequently. In the intervention group, the number of prescriptions for both first- and second-line antibiotics decreased without a commensurate rise in problems. 

Our findings are especially pertinent since disease-specific quality criteria highlight the necessity for a quinolone prescription rate of fewer than 5% in adult women with cystitis. The intervention group almost passed this barrier, demonstrating significant progress in meeting the standards.  

This study adds to the growing body of knowledge on antibiotic stewardship in primary care by using a multidimensional approach. The approach includes educating medical personnel and patients, sharing information about antibiotic resistance in diverse places, and providing frequent feedback on the frequency of antibiotic prescriptions. According to the research, this all-encompassing strategy has a significant impact on doctors’ prescription behaviors. 

According to the study, practices with a higher percentage of second-line prescriptions were more effective in minimizing antibiotic prescriptions over the course of the year. This lends credence to the notion that directing therapy to high-volume prescribers may be an effective strategy for improving outcomes. 

The authors of the research recognize that the COVID-19 pandemic may have had an impact on the drop in fluoroquinolone prescriptions found in their analysis, but they conclude that the intervention may have been more successful due to less attention dedicated to more limited usage during the pandemic. This is an effective intervention because it takes into account the fact that first-time and recurrent UTIs have varied rates of localized resistance.

Concentrating on frequent UTIs and using tight data extraction methods produced a more accurate image than less focused processes might. Despite its accomplishments, the study admits to a few flaws, such as the lack of blinding in practice teams and certain reporting biases. The study’s authors suggest that high prescribers engage in peer-to-peer discussion of course content and prescription rates as a potential future therapy. 

This groundbreaking study not only challenges traditional thinking on how to treat urinary tract infections with antibiotics, but it also paves the way for more comprehensive treatments to be used in primary care, which is a positive move in the fight against antibiotic resistance. The ramifications of this study for antibiotic prescription outside of Germany should not be overlooked.

The intervention’s apparent effectiveness implies that a similar approach may be implemented on a larger scale in other countries, where quinolone prescription rates range from 3% in Sweden to 22% in Belgium. The study also sheds insight on the critical balancing act that occurs between antibiotic usage and the development of resistance. The inclusion of regional resistance data strengthens antibiotic stewardship by allowing clinicians to make more educated treatment decisions. 

Antibiotic prescriptions have been dropping in the intervention group, which is consistent with new information regarding antibiotic alternatives. More than a decade ago, antibiotic prescription rates of 80 to 100 percent for women with UTIs were identified as a quality indicator. However, new evidence suggesting non-antibiotic treatment as a viable first-line option has rendered this signal obsolete. 

Despite evidence from qualitative research and surveys suggesting many women are willing to explore alternatives to antibiotics for UTIs, the number of women who actually acquire medications for UTIs ranges from 67% to 87% internationally. The outcome of this trial in increasing the proportion of UTIs treated without antibiotics is consistent with the recommendations of several guidelines that call for a new approach to UTI therapy. 

The lack of an increase in antibiotic prescriptions over the last year implies that the multimodal strategy is working. This demonstrates not just the potential of such medicines but also how crucial it is to continue altering prescriber behavior. The study proposes that high prescribers be especially targeted in order to enhance treatment results.

Incentives to enhance peer discussion of instructional materials and prescription rates may help pre-existing quality circles. The study, like the Swedish Strategic Program for the Rational Use of Antimicrobial Medication and Resistance Surveillance (STRAMA), offers personalized strategies to attain the best results. 

This groundbreaking study heralds a new era in the management of UTIs by demonstrating how a complete multimodal intervention may successfully induce the essential adjustment in physicians’ antibiotic prescribing practices. The study not only lays out a framework for future interventions, but it also underlines the importance of regional resistance data in directing treatment decisions and boosting worldwide antibiotic stewardship initiatives. 

Journal Reference  

Schmiemann, G., Greser, A., Maun, A., Bleidorn, J., Schuster, A., Miljukov, O., … Gágyor, I. (2023). Effects of a multimodal intervention in primary care to reduce second line antibiotic prescriptions for urinary tract infections in women: parallel, cluster randomised, controlled trial. Retrieved from https://www.bmj.com/content/383/bmj-2023-076305 

Leave a Reply

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses

Up arrow